Press Release Source: IDenta Corp. U.S. State Department Submits Second Order for IDenta Drug Detection Products Wednesday May 17, 10:23 am ET JERUSALEM, May 17 /PRNewswire-FirstCall/ -- IDenta Corp. (OTC Pink Sheets: IDTA - News) announced today that it has received its second order from the U.S. Department of State. The transaction was completed through its U.S. representative, Millennium Security Solutions (MSS). This is the second order for IDenta's drug detection products from the State Department in the last 30 days, and is reported to be substantially larger than the first contract. ADVERTISEMENT "We are building confidence in two significant areas with the Federal Government," explained Michael Phipps, CEO of Millennium Security Solutions (MSS). "First we had to build the confidence that IDenta's products could do the job in the field, and by receiving this order in such a short period of time, we know the products are performing exactly as represented. Second, we are building confidence in IDenta's ability to deliver significant orders within the agreed timeframe. We have been assured by IDenta executives that these size orders are well within their current production and delivery capabilities." This State Department order is believed to be headed for an unnamed country in southeast Asia. The first order was destined for Central America. There are no firm estimates of the total U.S. government expenditures on drug detection products such as IDenta's, but is expected to exceed $50 million per year. About Millennium Security Millennium Security Solutions, headquartered in McLean, Virginia develops unique security solutions for all levels of government, corporations and educational institutions. MSS focuses on proven state of the art technology with expert integration in order to solve our customer's specific needs. Millennium has also begun to provide sample kits to qualified individuals, businesses and industry and public media in the consumer, civilian, and governmental marketplaces who believe the kits may be beneficial to their organizations. For further information please call 703-752-3755 to submit a request for samples. http://www.millss.com About IDenta IDenta Corporation is one of the world's leading providers of proprietary on-site drug detection kits for governmental, professional and civilian use. Information concerning IDenta's business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at http://www.IDenta.biz and http://www.drugsdetector.com IDenta and Millennium support "D.A.M.M.A.D.D.," Dads and Mad Moms Against Drug Dealers, (http://www.dammadd.org ) For Investor Relations, lobbying interests or information concerning IDenta's products internationally contact:
For Investor Relations in the United States contact:
Randy Jacobs, SITCOM LLC IDentaNews*sitcomllc.com +1-800-316-9437
Coulda Shoulda Woulda
posted
i dont believe it
i dont believe that the us govt does business with pinksheet companies
a pr is not enough. most are lies
Superbee383
posted
Isn't a bank insured by the govt? What about banks that trade on the pink sheets? What about FINN, amongst others? And from what I read, IDTA did alot of trade shows, and travelled around the states quite a bit last year showing their product to many different police depts. getting contracts/sales.
J_U_ICE
posted
It's a good sign that the State dept submitted a 2nd order within 30 days of the first products must work well
J_U_ICE
posted
IDenta Drug & Explosives Detection Products Selected by French Government Agencies Mar 11, 2008 11:08:00 AM View Additional ProfilesJERUSALEM -- (MARKET WIRE) -- 03/11/08 -- IDenta Corp. (PINKSHEETS: IDTA) announced today that IDenta Alert explosive detectors and IDenta Stinger drug detectors have been officially selected by numerous police and governmental agencies in France. The announcement comes after a weeklong trade mission to that country during which company officials attended numerous high level meetings arranged by IDenta's French representatives, IBTEC.
"The French officials we met with are definitely convinced of the superiority of our products," boasted IDTA CEO Yaacov Shoham. Meetings were held at the French Laboratories of Police Science in Lyon (drug detection) and Marseilles (explosives detection), and with French Customs, the French Interior Minister and Gendarmerie Nationale in Paris. "This is the fulfillment of an important representation we made long ago to our shareholders concerning the progress IDenta has been making around the world. Significant changes like this one, now occurring in France, which we have been working on for over two years, take a long, long time to occur. We now believe within the year, all of the French agencies who use drug and explosive detection products will be working exclusively with IDenta."
To date in 2008, IDenta has received five substantial orders from various French agencies. The company projects that orders from France could total over one million dollars in the next year.
In another important development at the explosive laboratory in Marseilles, Shoham was informed that IDenta Alert explosives detectors performed with very high marks in a recently conducted large scale testing. A formal report, similar to one issued by the Police Science laboratory in Lyon in February of 2006 concerning IDenta's superior drug detection products, is expected to be released in the near future.
ABOUT IDENTA
Since 2003, IDenta Corporation has become recognized as a worldwide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally, contact: Yaacov Shoham IDenta Corp. CEO Tel: +972-52-6554487 fpi*drugsdetector.com
For Investor Relations in the US, contact: Randy Jacobs Corporate Spokesman IDentaNews*sitcomllc.com 1-800-316-9437
For information about the Accutest� - IDenta products in the US, please contact: Mr. Eyal Golan COO JANT PHARMACAL CORPORATION 16255 Ventura Blvd. #505 Encino, CA 91436 Toll Free: 800-676-5565 http://www.accutest.net